Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Amadeus IT Group, ams, Delivery Hero, Econocom, HelloFresh, Indra Sistemas, Ingenico, Just Eat Takeaway.com, Korian, Nexi, Outokumpu, Soitec et Worldline.  - We intend to resume coverage of some or all of these companies once a new analyst has joined us. In the meantime, we will continue to monitor the newsflow of these issuers in our morning document. - Previous credit o...

Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Amadeus IT Group, ams, Delivery Hero, Econocom, HelloFresh, Indra Sistemas, Ingenico, Just Eat Takeaway.com, Korian, Nexi, Outokumpu, Soitec et Worldline.  - We intend to resume coverage of some or all of these companies once a new analyst has joined us. In the meantime, we will continue to monitor the newsflow of these issuers in our morning document. - Previous credit o...

Valneva : Strong H1 - Key Lyme vaccine catalyst ahead in Q4

Valneva delivered a solid H1 and reaffirmed its 2025 guidance. The company’s cash position, standing at €161m, is sufficient to fund operations through 2027e, providing solid financial visibility. Looking ahead, the next key catalyst is the Phase III data readout for VLA15, Valneva’s Lyme disease v

Deliveroo: strengthening growth/margin profile ahead of DoorDash deal

Post-another strong print and FY guidance upgrade, fuelled by a recovery in order growth and market share gains, we see more credibility in Deliveroo's MT targets and have increased our EBITDA and FCF estimates by 8% and 11%. PT unchanged at 180p to stick to the DoorDash offer, which we view as fai

Valneva : FDA lifts age restriction on IXCHIQ

Valneva announced yesterday that the FDA has lifted its recommended pause on the use of IXCHIQ in individuals aged 60+, following updated safety data. This follows a similar decision by the EMA in July, which lifted temporary restrictions after a safety review. Despite regulatory clearance from bot